Annual report pursuant to Section 13 and 15(d)

Share-Based Compensation - Summary of Activities Under Share-Based Compensation Plans (Detail)

v3.22.4
Share-Based Compensation - Summary of Activities Under Share-Based Compensation Plans (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding and nonvested as of December 31, 2020, Number of Shares [1] 3,400  
Granted, Number of Shares [2] 3,243  
Vested, Number of Shares [3] (1,081)  
Forfeited, Number of Shares [4] (1,024)  
Outstanding and nonvested as of December 31, 2021, Shares [1] 4,538 3,400
Number of Shares, Expected to vest as of December 31, 2021 [5] 4,033  
Outstanding and nonvested as of December 31, 2020, Weighted Average Grant Date Fair Value Per Share [1] $ 45.26  
Granted, Weighted Average Grant Date Fair Value Per Share [2] 28.01  
Vested, Weighted Average Grant Date Fair Value Per Share [3] 47.66  
Forfeited, Weighted Average Grant Date Fair Value Per Share [4] 41.84  
Outstanding and nonvested as of December 31, 2021, Weighted Average Grant Date Fair Value Per Share [1] 33.14 $ 45.26
Expected to vest as of December 31, 2020, Weighted Average Grant Date Fair Value Per Share [5] $ 32.45  
SARs [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Awards Outstanding, Beginning Balance [6] 2,622  
Granted, Number of Awards 784,000  
Exercised, Number of Awards [7] (82)  
Forfeited, Number of Awards (250)  
Number of Awards Outstanding, Ending Balance [6] 3,074 2,622
Number of Awards Exercisable, Ending Balance [8] 2,290  
Number of Awards Vested and expected to vest, Ending Balance [8] 3,040  
Weighted Average Exercise Price Per Award Outstanding, Beginning Balance [6] $ 27.10  
Granted, Weighted Average Exercise Price Per Award 14.45  
Exercised, Weighted Average Exercise Price Per Award [7] 20.58  
Forfeited, Weighted Average Exercise Price Per Award 25.08  
Weighted Average Exercise Price Per Award Outstanding, Ending Balance [6] 24.21 $ 27.10
Exercisable, Weighted Average Exercise Price Per Award, Ending Balance [8] 27.55  
Weighted Average Exercise Price Per Award, Vested and expected to vest, Ending Balance [8] $ 24.32  
Weighted Average Remaining Contractual Term Outstanding [6] 4 years 7 months 6 days 3 years 9 months 18 days
Exercisable Weighted Average Remaining Contractual Term [8] 2 years 9 months 18 days  
Weighted Average Remaining Contractual Term, Vested and expected to vest [8] 4 years 7 months 6 days  
Aggregate Intrinsic Value Outstanding [6] $ 0.3 $ 36.3
Exercisable, Aggregate Intrinsic Value [8] 0.0  
Aggregate Intrinsic Value, Vested and expected to vest [8] $ 0.3  
[1] Includes 520,138 and 913,388 performance based stock unit awards as of December 31, 2022 and 2021, respectively, which represents the maximum amount that can vest.
[2] Includes 559,430 performance-based stock unit awards.
[3] Includes 270,021 performance-based stock unit awards.
[4] Includes 682,659 performance-based stock unit awards.
[5] Includes 136,409 performance-based stock unit awards.
[6] Includes 0.8 million performance condition SARs as of December 31, 2022 and 2021.
[7] Includes less than 0.1 million performance condition SARs.
[8] Includes 0.8 million performance condition SARs.